By Roderick L. Abad / Contributor DENMARK-BASED pharmaceutical company Novo Nordisk continues its investment in the Philippines and its people by partnering with a local hospital to promote proper diabetes care in the country. By way of a memorandum of agreement it signed with the St. Luke’s Medical Center (SLMC)
↧